Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533

Quantification of translocation-specific ctDNA provides an integrating parameter for early assessment of treatment response and risk stratification in Ewing sarcoma

(2021) Manuela Krumbholz et al.   CLINICAL CANCER RESEARCH

Circulating tumour DNA sequencing to determine therapeutic response and identify tumour heterogeneity in patients with paediatric solid tumours

(2021) Reda Stankunaite et al.   EUROPEAN JOURNAL OF CANCER

Integrating genomic features for non-invasive early lung cancer detection

(2020) Jacob J. Chabon et al.   NATURE

Assessment of somatic mutations in urine and plasma of Wilms tumor patients

(2020) Ana Carolina Kerekes Miguez et al.   Cancer Medicine

Assessment of circulating tumor DNA in pediatric solid tumors: The promise of liquid biopsies

(2019) Samuel D. Abbou et al.   PEDIATRIC BLOOD & CANCER

Liquid biopsy in breast cancer: A comprehensive review

(2019) Sahar Alimirzaie et al.   CLINICAL GENETICS

Circulating biomarkers for early detection and clinical management of colorectal cancer

(2019) María Marcuello et al.   MOLECULAR ASPECTS OF MEDICINE

Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children’s Oncology Group AREN0532 and AREN0533 Study Report

(2019) David B. Dix et al.   JOURNAL OF CLINICAL ONCOLOGY

Progress toward liquid biopsies in pediatric solid tumors

(2019) Daniel A. Weiser et al.   CANCER AND METASTASIS REVIEWS

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review

(2018) Jason D. Merker et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma

(2018) Valeria Spina et al.   BLOOD

The classification of pediatric and young adult renal cell carcinomas registered on the Children's Oncology Group (COG) protocol AREN03B2 after focused genetic testing

(2018) Mariana M. Cajaiba et al.   CANCER

CIRCULATING TUMOR DNA ANALYSIS ENABLES MOLECULAR CHARACTERIZATION OF PEDIATRIC RENAL TUMORS AT DIAGNOSIS

(2018) Irene Jiménez et al.   INTERNATIONAL JOURNAL OF CANCER

Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children’s Oncology Group AREN0533 Study

(2018) David B. Dix et al.   JOURNAL OF CLINICAL ONCOLOGY

Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group

(2018) David S. Shulman et al.   BRITISH JOURNAL OF CANCER

Somatic TP53 Mutations Are Detectable in Circulating Tumor DNA from Children with Anaplastic Wilms Tumors

(2018) Taryn D. Treger et al.   Translational Oncology

Impact of Surveillance Imaging Modality on Survival After Recurrence in Patients With Favorable-Histology Wilms Tumor: A Report From the Children’s Oncology Group

(2018) Elizabeth A. Mullen et al.   JOURNAL OF CLINICAL ONCOLOGY

Application of Cell-free DNA Analysis to Cancer Treatment

(2018) Ryan B. Corcoran et al.   NEW ENGLAND JOURNAL OF MEDICINE

Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditions

(2017) Lisanne F. van Dessel et al.   Molecular Oncology

Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

(2017) Christopher Abbosh et al.   NATURE

A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor

(2017) Samantha Gadd et al.   NATURE GENETICS

Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors

(2017) Viktor A. Adalsteinsson et al.   Nature Communications

Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes

(2016) Qing Kang et al.   CLINICAL BIOCHEMISTRY

Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children’s Oncology Group

(2016) Eric J. Gratias et al.   JOURNAL OF CLINICAL ONCOLOGY

Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients

(2016) Jacob J. Chabon et al.   Nature Communications

Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy

(2016) C. Alix-Panabieres et al.   Cancer Discovery

Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer

(2015) Isaac Garcia-Murillas et al.   Science Translational Medicine

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

(2014) C. Bettegowda et al.   Science Translational Medicine

Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA

(2014) D. A. Haber et al.   Cancer Discovery

Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer

(2013) Sarah-Jane Dawson et al.   NEW ENGLAND JOURNAL OF MEDICINE

A method for counting PCR template molecules with application to next-generation sequencing

(2011) J. A. Casbon et al.   NUCLEIC ACIDS RESEARCH

Treatment of relapsed Wilms tumors: lessons learned

(2009) Filippo Spreafico et al.   Expert Review of Anticancer Therapy

Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group

(2007) Marcio Malogolowkin et al.   PEDIATRIC BLOOD & CANCER